as 09-12-2025 4:00pm EST
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.
Founded: | 1904 | Country: | United States |
Employees: | N/A | City: | RADNOR |
Market Cap: | 9.4B | IPO Year: | 2019 |
Target Price: | $16.54 | AVG Volume (30 days): | 11.2M |
Analyst Decision: | Buy | Number of Analysts: | 13 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 1.01 | EPS Growth: | 94.25 |
52 Week Low/High: | $10.82 - $27.83 | Next Earning Date: | 10-24-2025 |
Revenue: | $6,665,800,000 | Revenue Growth: | -2.34% |
Revenue Growth (this year): | -0.52% | Revenue Growth (next year): | 2.34% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
SUMME GREGORY L | AVTR | N/A | Aug 21 '25 | Buy | $12.56 | 100,000 | $1,256,000.00 | 200,000 |
AVTR Breaking Stock News: Dive into AVTR Ticker-Specific Updates for Smart Investing
PR Newswire
3 months ago
StockStory
3 months ago
Insider Monkey
3 months ago
Argus Research
3 months ago
StockStory
3 months ago
StockStory
3 months ago
StockStory
3 months ago
StockStory
3 months ago
The information presented on this page, "AVTR Avantor Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.